NEW YORK (Reuters Health) – Some lung cancer patients classified as T3 by the new TNM classification, seventh edition should be redefined as T2b, say researchers from The University of Texas M. D. Anderson Cancer Center in Houston.

“Outcome prediction should be individualized for each patient,” Dr. Edward S. Kim told Reuters Health. “Even within one stage, tumor and patients characteristics may help identify individuals who will have better outcome, and thus allow us to tailor treatment commensurate with each patient’s prognosis.”